IMMUNOTHÉRAPIE ANTITUMORALE
- 专利权人:
- MEDIOLANUM FARMACEUTICI S.P.A.
- 发明人:
- 申请号：
- EP09776746.1
- 公开号：
- EP2310044B1
- 申请日:
- 2009.06.16
- 申请国别(地区):
- EP
- 年份:
- 2016
- 代理人:
- 摘要：
- The present invention relates to the use of telomerase-derived peptides for the treatment of any cancer patients, particularly for the treatment of patients with renal or prostate cancer.
- 来源网站：
- 中国工程科技知识中心
